US Tarrif Impact in reshaping

1. How the US Tariff Impact is Reshaping the Healthcare Industry As the global trade landscape shifts, the healthcare industry-spanning pharma, medtech, & providers-is navigating a new wave of challenges. Here’s how tariffs are redefining cost structures, supply chains, and access

2. Pharma Industry Cost vs. Resilience Tariffs threaten access to low-cost generics, which rely on imports from India & China & already face shrinking margins Most US APIs are imported; tariffs raise costs & risk supply disruptions

3. Medical Devices Supply Chain & Profit Pressures Tariffs drive firms to diversify sourcing & invest in automation Cross-border manufacturing, especially with Mexico & China, is vulnerable to new levies

4. Providers & Patients Financial Strain Rising supply costs & delayed equipment upgrades burden hospitals, especially in rural areas

5. Corporate Strategy Operational Shifts Companies are expanding US manufacturing, investing in domestic capacity, and reconfiguring supply chains to reduce tariff exposure

6. Outlook Tariffs remain a top operational risk, accelerating supply chain transformation and regionalization across healthcare